The company Boehringer Ingelheim is continuing its support for the Gutenberg Health Study (GHS) with a sum of three million Euros by the end of 2017. …
Göttinger Pharmakologen unter Leitung des DZHK-Wissenschaftlers Prof. Dr. Ali El-Armouche erforschen neue Therapie bei Herzmuskelschwäche: Durch…
Scientific know-how and skills of external partners are sought after in the German Centre for Cardiovascular Research (DZHK). Therefore it is now…
